Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 812 shares, an increase of 7,281.8% from the June 15th total of 11 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 3,083 shares, the days-to-cover ratio is currently 0.3 days.
Innovator IBD Breakout Opportunities ETF Trading Down 0.7%
Shares of Innovator IBD Breakout Opportunities ETF stock traded down $0.35 during trading hours on Friday, hitting $46.66. 1,926 shares of the company were exchanged, compared to its average volume of 4,263. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41. The business has a 50-day moving average of $46.84 and a 200-day moving average of $42.25. The stock has a market capitalization of $16.33 million, a price-to-earnings ratio of 28.69 and a beta of 1.03.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Osaic Holdings Inc. raised its position in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after acquiring an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC boosted its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares in the last quarter. Finally, Susquehanna International Group LLP boosted its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares in the last quarter.
Innovator IBD Breakout Opportunities ETF Company Profile
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
Read More
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
